US$ 28.62
micro dose semaglutide One Size Does Not Fit All: Understanding Microdosing for Diabetes in Multidose Pens Microdose GLP-1 — Zera Health
Description
Mounjaro and Zepbound mimic the effects of GLP-1 as well as GIP, a type of hormone that helps regulate blood sugar by stimulating insulin

GLP-1 (Glucagon Like Peptide-1) is a transcriptional product of proglucagon gene as same as glucagon and one of gastrointestinal hormone which is secreted from L cells of lower section of the small intestine

GIP receptor activation adds: Enhanced fat metabolism: GIP receptors on adipose tissue promote fat breakdown and reduce fat storage, adding a metabolic dimension to weight loss beyond appetite suppression alone Additive appetite suppression: GIP and GLP-1 receptor activation together produce greater appetite reduction than either pathway alone Improved insulin sensitivity: The combination improves peripheral insulin sensitivity more effectively than GLP-1 activation alone particularly relevant for patients with insulin resistance or type 2 diabetes Tirzepatide is sold under the brand names Mounjaro (diabetes indication) and Zepbound (obesity indication) and is also available as a compounded medication

Provider oversight required FDA boxed warnings and contraindications apply at any dose

doi: 10.1007/S11739-016-1583-7
